AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax
2022 · Leukemia Research Reports · 3 citations
https://doi.org/10.1016/j.lrr.2022.100333
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
807
Citations
10
h-index
10
i10-index
Suparna Nanua is an academic researcher from Rochester General Hospital. The author has contributed to research in topics: Asthma and respiratory diseases & Virus-based gene therapy research & Immune Cell Function and Interaction. The author has an h-index of 10, co-authored 15 publications.
Click to start Chat